Guangzhou LBP Medicine Science & Technology Co., Ltd.

¥17.65As of Sun 8 Nov 2026, 12:00 UTC
SSE:688393Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (14.90%)
Div yield 0.57%
ROE (3.22%)
Medical Instruments & Supplies
Beta (5Y) 0.60
PE TTM —
TSR TTM (30.65%)
Mkt cap ¥1.651B
ROIC (5.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥23
28.61%
0.24%
Hold 3|2|12|3|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.21
0.23
0.23
0.25
3.32%
(0.53%)
(2.65%)
12.97%
Revenue¥M
208.8
203.4
204.4
212.3
8.55%
2.75%
(1.93%)
2.82%
Peers (US$247.6M)
Cap (US$)
PE
287.5M
47.80x
250.7M
23.39x
Capital
TTM
5Y
10Y
Leveragex
4.800
(0.054)
(0.047)
EBIT/Intx
1.383
0.275
0.258
Own earn%
(27.78)
(70.10)
(81.16)
Sh yield%
25.09
28.55
27.98
Owners
Insiders/Inst%
6.32
45.07
Short interest%
5.52
SBC / revenue%
1.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
16–23
$1 testx
—
Incr. ROIC%
21